XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statement of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (loss)
Accumulated Deficit
Redeemable convertible preferred stock beginning balance (in shares) at Dec. 31, 2020 351,844,340        
Redeemable convertible preferred stock beginning balance at Dec. 31, 2020 $ 501,881        
Redeemable convertible preferred stock ending balance (in shares) at Mar. 31, 2021 351,844,340        
Redeemable convertible preferred stock ending balance at Mar. 31, 2021 $ 501,881        
Balance at the beginning of the period (in shares) at Dec. 31, 2020   130,312,838      
Balance at the beginning of the period at Dec. 31, 2020 (213,717) $ 13 $ 39,769 $ 25 $ (253,524)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of vested options (in shares)   1,904,186      
Issuance of common stock upon exercise of options 1,410   1,410    
Repurchase of early exercised stock options (in shares)   (18,567)      
Issuance of common stock upon early exercise of unvested options ( in shares)   319,883      
Vesting of early exercised stock options 223   223    
Share-based compensation expense 11,392   11,392    
Change in accumulated other comprehensive income (loss) (45)     (45)  
Net loss (12,838)       (12,838)
Balance at the end of the period (in shares) at Mar. 31, 2021   132,518,340      
Balance at the end of the period at Mar. 31, 2021 $ (213,575) $ 13 52,794 (20) (266,362)
Redeemable convertible preferred stock beginning balance (in shares) at Dec. 31, 2020 351,844,340        
Redeemable convertible preferred stock beginning balance at Dec. 31, 2020 $ 501,881        
Redeemable convertible preferred stock ending balance (in shares) at Jun. 30, 2021 0        
Redeemable convertible preferred stock ending balance at Jun. 30, 2021 $ 0        
Balance at the beginning of the period (in shares) at Dec. 31, 2020   130,312,838      
Balance at the beginning of the period at Dec. 31, 2020 (213,717) $ 13 39,769 25 (253,524)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (81,392)        
Balance at the end of the period (in shares) at Jun. 30, 2021   538,883,451      
Balance at the end of the period at Jun. 30, 2021 $ 1,585,986 $ 54 1,920,936 (88) (334,916)
Redeemable convertible preferred stock beginning balance (in shares) at Mar. 31, 2021 351,844,340        
Redeemable convertible preferred stock beginning balance at Mar. 31, 2021 $ 501,881        
Preferred Stock          
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares) (351,844,340)        
Conversion of redeemable convertible preferred stock to common stock upon initial public offering $ (501,881)        
Redeemable convertible preferred stock ending balance (in shares) at Jun. 30, 2021 0        
Redeemable convertible preferred stock ending balance at Jun. 30, 2021 $ 0        
Balance at the beginning of the period (in shares) at Mar. 31, 2021   132,518,340      
Balance at the beginning of the period at Mar. 31, 2021 (213,575) $ 13 52,794 (20) (266,362)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of vested options (in shares)   859,343      
Issuance of common stock upon exercise of options 1,161   1,161    
Repurchase of early exercised stock options (in shares)   (9,897)      
Issuance of common stock net settlement of restricted stock units (in shares)   730,186      
Issuance of common stock upon net settlement of restricted stock units (10,273)   (10,273)    
Vesting of common stock warrants 2,102   2,102    
Issuance of common stock upon Initial public offering, net of issuance costs (in shares)   52,272,727      
Issuance of common stock upon initial public offering, net of issuance costs 1,312,338 $ 7 1,312,331    
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)   351,844,340      
Conversion of redeemable convertible preferred stock to common stock upon initial public offering 501,881 $ 34 501,847    
Reclassification of redeemable convertible preferred stock warrant liabilities to common stock and additional paid-in capital upon initial public offering 5,438   5,438    
Issuance of common stock upon exercise of common stock warrants (in shares)   668,412      
Issuance of common stock upon exercise of common stock warrants 0        
Share-based compensation expense 55,536   55,536    
Change in accumulated other comprehensive income (loss) (68)     (68)  
Net loss (68,554)       (68,554)
Balance at the end of the period (in shares) at Jun. 30, 2021   538,883,451      
Balance at the end of the period at Jun. 30, 2021 $ 1,585,986 $ 54 1,920,936 (88) (334,916)
Redeemable convertible preferred stock beginning balance (in shares) at Dec. 31, 2021 0        
Redeemable convertible preferred stock beginning balance at Dec. 31, 2021 $ 0        
Redeemable convertible preferred stock ending balance (in shares) at Mar. 31, 2022 0        
Redeemable convertible preferred stock ending balance at Mar. 31, 2022 $ 0        
Balance at the beginning of the period (in shares) at Dec. 31, 2021   541,383,518      
Balance at the beginning of the period at Dec. 31, 2021 1,573,426 $ 54 1,993,055 (2,230) (417,453)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of vested options (in shares)   1,604,022      
Issuance of common stock upon exercise of options 2,285   2,285    
Repurchase of early exercised stock options (in shares)   (22,751)      
Issuance of common stock net settlement of restricted stock units (in shares)   642,827      
Issuance of common stock upon net settlement of restricted stock units (4,702)   (4,702)    
Vesting of common stock warrants 2,102   2,102    
Share-based compensation expense 37,005   37,005    
Change in accumulated other comprehensive income (loss) (5,886)     (5,886)  
Net loss (60,598)       (60,598)
Balance at the end of the period (in shares) at Mar. 31, 2022   543,607,616      
Balance at the end of the period at Mar. 31, 2022 $ 1,543,632 $ 54 2,029,745 (8,116) (478,051)
Redeemable convertible preferred stock beginning balance (in shares) at Dec. 31, 2021 0        
Redeemable convertible preferred stock beginning balance at Dec. 31, 2021 $ 0        
Redeemable convertible preferred stock ending balance (in shares) at Jun. 30, 2022 0        
Redeemable convertible preferred stock ending balance at Jun. 30, 2022 $ 0        
Balance at the beginning of the period (in shares) at Dec. 31, 2021   541,383,518      
Balance at the beginning of the period at Dec. 31, 2021 1,573,426 $ 54 1,993,055 (2,230) (417,453)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (105,286)        
Balance at the end of the period (in shares) at Jun. 30, 2022   545,933,730      
Balance at the end of the period at Jun. 30, 2022 $ 1,534,557 $ 54 2,067,435 (10,193) (522,739)
Redeemable convertible preferred stock beginning balance (in shares) at Mar. 31, 2022 0        
Redeemable convertible preferred stock beginning balance at Mar. 31, 2022 $ 0        
Redeemable convertible preferred stock ending balance (in shares) at Jun. 30, 2022 0        
Redeemable convertible preferred stock ending balance at Jun. 30, 2022 $ 0        
Balance at the beginning of the period (in shares) at Mar. 31, 2022   543,607,616      
Balance at the beginning of the period at Mar. 31, 2022 1,543,632 $ 54 2,029,745 (8,116) (478,051)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of vested options (in shares)   1,314,467      
Issuance of common stock upon exercise of options 1,543   1,543    
Repurchase of early exercised stock options (in shares)   (28,268)      
Issuance of common stock under employee stock purchase plan (in shares)   368,955      
Issuance of common stock under employee stock purchase plan 2,775   2,775    
Issuance of common stock net settlement of restricted stock units (in shares)   670,960      
Issuance of common stock upon net settlement of restricted stock units (3,878)   (3,878)    
Vesting of common stock warrants 2,102   2,102    
Share-based compensation expense 35,148   35,148    
Change in accumulated other comprehensive income (loss) (2,077)     (2,077)  
Net loss (44,688)       (44,688)
Balance at the end of the period (in shares) at Jun. 30, 2022   545,933,730      
Balance at the end of the period at Jun. 30, 2022 $ 1,534,557 $ 54 $ 2,067,435 $ (10,193) $ (522,739)